Amneal Pharmaceuticals (AMRX) Stock Chart & Stock Price History → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free AMRX Stock Alerts $6.71 +0.05 (+0.75%) (As of 05/13/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Amneal Pharmaceuticals Stock Price Performance5 Day Performance+3.71%1 Month Performance+21.56%3 Month Performance+15.29%6 Month Performance+46.99%Year-To-Date Performance+10.54%1 Year Performance+249.48% Receive AMRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyAmerica’s worst nightmare?What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. AMRX Stock Chart for Tuesday, May, 14, 2024 AMRX Chart by TradingView Amneal Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$6.66$6.71+0.75%$6.74$6.501.15 million shs$2.06 billion05/10/2024$6.47$6.66+2.94%$6.75$6.491.14 million shs$2.04 billion05/09/2024$6.59$6.47-1.82%$6.69$6.44808,905 shs$1.99 billion05/08/2024$6.51$6.59+1.23%$6.73$6.48904,294 shs$2.02 billion05/07/2024$6.65$6.51-2.11%$6.71$6.481.31 million shs$2.00 billion05/06/2024$6.76$6.65-1.63%$6.84$6.551.79 million shs$2.04 billion Get the Latest News and Ratings for AMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$6.21$6.76+8.86%$6.90$5.813.85 million shs$2.08 billion05/02/2024$6.12$6.21+1.47%$6.35$6.082.16 million shs$1.91 billion05/01/2024$6.05$6.12+1.16%$6.19$6.001.25 million shs$1.88 billion04/30/2024$5.94$6.05+1.85%$6.10$5.821.95 million shs$1.86 billion04/29/2024$5.87$5.94+1.19%$5.97$5.831.27 million shs$1.82 billion04/26/2024$5.90$5.87-0.51%$5.98$5.84959,053 shs$1.80 billion04/25/2024$6.05$5.90-2.48%$5.97$5.593.43 million shs$1.81 billion04/24/2024$5.40$6.05+12.04%$6.11$5.562.91 million shs$1.86 billion04/23/2024$5.37$5.40+0.56%$5.48$5.361.38 million shs$1.66 billion04/22/2024$5.42$5.37-0.92%$5.43$5.181.85 million shs$1.65 billion04/19/2024$5.36$5.42+1.12%$5.43$5.331.06 million shs$1.66 billion04/18/2024$5.46$5.36-1.83%$5.47$5.34843,278 shs$1.65 billion04/17/2024$5.45$5.46+0.18%$5.52$5.371.22 million shs$1.68 billion04/16/2024$5.54$5.45-1.62%$5.54$5.381.20 million shs$1.67 billion04/15/2024$5.52$5.54+0.36%$5.67$5.471.12 million shs$1.70 billion04/12/2024$5.69$5.52-2.99%$5.81$5.422.18 million shs$1.69 billion04/11/2024$5.70$5.69-0.18%$5.81$5.661.27 million shs$1.75 billion04/10/2024$5.73$5.70-0.52%$5.92$5.611.78 million shs$1.75 billion04/09/2024$6.00$5.73-4.50%$6.03$5.722.31 million shs$1.76 billion04/08/2024$6.12$6.00-1.96%$6.33$5.961.38 million shs$1.84 billion04/05/2024$5.96$6.12+2.68%$6.19$5.931.99 million shs$1.88 billion04/04/2024$6.02$5.96-1.00%$6.21$5.941.23 million shs$1.83 billion04/03/2024$5.81$6.02+3.61%$6.12$5.671.82 million shs$1.85 billion04/02/2024$6.05$5.81-3.97%$6.00$5.781.22 million shs$1.78 billion04/01/2024$6.06$6.05-0.17%$6.13$5.901.19 million shs$1.86 billion03/29/2024$6.06$6.06$6.21$5.972.88 million shs$1.86 billion03/28/2024$6.12$6.06-0.98%$6.21$5.972.88 million shs$1.86 billion03/27/2024$5.85$6.12+4.62%$6.15$5.711.91 million shs$1.88 billion03/26/2024$5.91$5.85-1.02%$6.00$5.811.90 million shs$1.80 billion03/25/2024$6.07$5.91-2.64%$6.09$5.90887,512 shs$1.81 billion03/22/2024$6.29$6.07-3.50%$6.29$6.012.23 million shs$1.86 billion03/21/2024$6.08$6.29+3.45%$6.33$6.191.03 million shs$1.93 billion03/20/2024$6.34$6.08-4.10%$6.32$5.981.22 million shs$1.86 billion03/19/2024$5.91$6.34+7.28%$6.46$5.793.21 million shs$1.94 billionDoes this chart look familiar? (Ad)Investors who understand when to get in — and when to get out… Can make a lot of money. Like in the chart, I showed you above…Get all the information here.03/18/2024$5.50$5.91+7.45%$5.91$5.482.00 million shs$1.81 billion03/15/2024$5.39$5.50+2.04%$5.52$5.352.23 million shs$1.69 billion03/14/2024$5.40$5.39-0.19%$5.40$5.251.06 million shs$1.65 billion03/13/2024$5.31$5.40+1.69%$5.47$5.26867,760 shs$1.66 billion03/12/2024$5.38$5.31-1.30%$5.48$5.281.07 million shs$1.63 billion03/11/2024$5.39$5.38-0.19%$5.49$5.36967,520 shs$1.65 billion03/08/2024$5.31$5.39+1.51%$5.52$5.291.11 million shs$1.65 billion03/07/2024$5.31$5.31$5.37$5.25929,357 shs$1.63 billion03/06/2024$5.34$5.31-0.56%$5.39$5.211.13 million shs$1.63 billion03/05/2024$5.40$5.34-1.11%$5.45$5.33935,995 shs$1.64 billion03/04/2024$5.47$5.40-1.28%$5.51$5.311.63 million shs$1.66 billion03/01/2024$5.52$5.47-0.91%$6.15$5.015.95 million shs$1.68 billion02/29/2024$5.52$5.52$5.62$5.373.37 million shs$1.69 billion02/28/2024$5.71$5.52-3.33%$5.66$5.481.80 million shs$1.69 billion02/27/2024$5.82$5.71-1.89%$5.81$5.372.15 million shs$1.75 billion02/26/2024$5.80$5.82+0.34%$5.92$5.671.44 million shs$1.78 billion02/23/2024$5.69$5.80+1.93%$5.81$5.61688,136 shs$1.78 billion02/22/2024$5.73$5.69-0.70%$5.91$5.67945,308 shs$1.74 billion02/21/2024$5.78$5.73-0.87%$5.84$5.65831,018 shs$1.76 billion02/20/2024$5.90$5.78-2.03%$5.87$5.751.22 million shs$1.77 billion02/19/2024$5.90$5.90$5.93$5.741.15 million shs$1.81 billion02/16/2024$5.89$5.90+0.17%$5.93$5.741.15 million shs$1.81 billion02/15/2024$5.82$5.89+1.20%$6.09$5.871.38 million shs$1.81 billion02/14/2024$5.60$5.82+3.93%$5.87$5.67991,486 shs$1.78 billion02/13/2024$5.85$5.60-4.27%$5.77$5.421.32 million shs$1.72 billion Related Companies: AMPH Stock Chart DCPH Stock Chart RCKT Stock Chart ZLAB Stock Chart ARVN Stock Chart KROS Stock Chart CPRX Stock Chart AGIO Stock Chart GERN Stock Chart VERA Stock Chart Receive AMRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AMRX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportGuard Against the Coming Financial UpheavalPorter & CompanyDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsThis 1 Biotech Stock has been shocking the marketsHuge AlertsElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amneal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.